Reply to C. Buttigliero et al and B. Biswas et al
- PMID: 28165905
- DOI: 10.1200/JCO.2016.71.7249
Reply to C. Buttigliero et al and B. Biswas et al
Comment on
-
Survival Analyses of Patients With Metastatic Renal Cancer Treated With Targeted Therapy With or Without Cytoreductive Nephrectomy: A National Cancer Data Base Study.J Clin Oncol. 2016 Sep 20;34(27):3267-75. doi: 10.1200/JCO.2016.66.7931. Epub 2016 Jun 20. J Clin Oncol. 2016. PMID: 27325852 Free PMC article.
-
Immediate or Delayed Nephrectomy in Patients With Metastatic Renal Cancer Who Are Receiving Targeted Agents: Is the Analysis at Risk for Guarantee-Time Bias?J Clin Oncol. 2017 Apr 10;35(11):1264. doi: 10.1200/JCO.2016.69.3580. Epub 2017 Feb 6. J Clin Oncol. 2017. PMID: 28165894 No abstract available.
-
Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy: Scientifically Relevant or Natural Selection?J Clin Oncol. 2017 Apr 10;35(11):1265-1266. doi: 10.1200/JCO.2016.70.8156. Epub 2017 Feb 6. J Clin Oncol. 2017. PMID: 28165897 No abstract available.
Similar articles
-
Immediate or Delayed Nephrectomy in Patients With Metastatic Renal Cancer Who Are Receiving Targeted Agents: Is the Analysis at Risk for Guarantee-Time Bias?J Clin Oncol. 2017 Apr 10;35(11):1264. doi: 10.1200/JCO.2016.69.3580. Epub 2017 Feb 6. J Clin Oncol. 2017. PMID: 28165894 No abstract available.
-
Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy: Scientifically Relevant or Natural Selection?J Clin Oncol. 2017 Apr 10;35(11):1265-1266. doi: 10.1200/JCO.2016.70.8156. Epub 2017 Feb 6. J Clin Oncol. 2017. PMID: 28165897 No abstract available.
-
Kidney cancer: Cytoreductive nephrectomy improves outcomes in the era of targeted therapy.Nat Rev Urol. 2016 Aug;13(8):438. doi: 10.1038/nrurol.2016.127. Epub 2016 Jul 5. Nat Rev Urol. 2016. PMID: 27377158 Review. No abstract available.
-
Is Underutilization of Cytoreductive Nephrectomy in Patients With Metastatic Renal Cancer Contributing to Inferior Survival?J Clin Oncol. 2016 Sep 20;34(27):3235-6. doi: 10.1200/JCO.2016.68.4050. Epub 2016 Aug 15. J Clin Oncol. 2016. PMID: 27528717 No abstract available.
-
Role of partial nephrectomy as cytoreduction in the management of metastatic renal cell carcinoma.Minerva Urol Nefrol. 2015 Jun;67(2):149-56. Epub 2015 Feb 3. Minerva Urol Nefrol. 2015. PMID: 25645343 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical